How Hyperphosphatemia Medications Work

Hyperphosphatemia is a condition characterized by elevated levels of phosphate in the blood. The primary goal of treatment is to reduce serum phosphate levels and prevent complications such as bone disease, cardiovascular calcification, and secondary hyperparathyroidism.

Treatment Options

• Gold Standard: Phosphate binders (e.g., sevelamer) work by binding to dietary phosphate in the gastrointestinal tract, preventing its absorption into the bloodstream. This reduces serum phosphate levels and helps maintain a balance between phosphate and calcium.
• Alternatives:
  • Calcimimetics (e.g., cinacalcet) work by activating the calcium-sensing receptor in the parathyroid gland, reducing parathyroid hormone secretion and subsequent phosphate reabsorption in the kidneys.
  • Vitamin D analogs (e.g., calcitriol) increase intestinal absorption of calcium, which can help reduce phosphate absorption and levels.
  • Dialysis is a last resort for patients with end-stage renal disease or severe hyperphosphatemia, removing excess phosphate from the blood through hemodialysis or peritoneal dialysis.